Store
IVD Procedure Volumes, 2021-2026
Publication Date: March 23, 2022
Tags: Coagulation, COVID-19, Diagnostic Instruments, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, Molecular Diagnostics, Oncology and Cancer, Point-of-Care (POC) Testing
Pages: 305
SKU: 22-025
There were over 100 billion IVD procedures in 2021. These represent sources of revenue for IVD companies and laboratories, but they also represent gateway activities to a broad range of healthcare events including surgeries, pharmaceutical prescriptions imaging procedures and physician office visits. Finding information for procedure volumes can be difficult as companies do not publish this information. For this reason, Kalorama has published IVD Procedure Volumes, 2021-2026, a guide where procedures on a wide variety of tests are estimated based on information in public sources, Kalorama databases, revenue estimates, country medical authorities and medical journals. This comprehensive report analyzes global trends in IVD procedural volume.
This comprehensive report provides essential calculations and estimates of both current and future volumes for a wide range of diagnostic tests, including pricing analysis. It is an indispensable tool for new market entrants and existing product marketers looking to understand the market opportunity.
Report Highlights:
- IVD Test Procedure Volume and Pricing Estimates for Key Segments:
- Worldwide IVD Market and Test Volume
- Point-of-Care (POC) Market and Test Volume
- Clinical Chemistry Market and Test Volume
- Molecular Market and Test Volume
- Hematology Market and Test Volume
- Coagulation Market and Test Volume
- Microbiology Market and Test Volume
- Blood Banking Market and Test Volume
- COVID-19 Market and Test Volume
- Histology/Cytology Market and Test Volume
- Immunoassay Market and Test Volume
IVD Testing Segments and Global Markets:
- The report includes profiles of top IVD market competitors, detailing procedural volume by type wherever possible.
- Analysis covers point-of-care and laboratory tests categorized by testing technology, with clinical chemistry, hematology, and immunoassays leading in the number of tests performed worldwide.
- Molecular assays are highlighted for their growing procedural volume and sales, especially influenced by the pandemic, though they represent a smaller portion of total IVD activities.
- Conventional microbiology, coagulation (hemostasis), histology, and cytology are among the most widely employed IVD testing technologies.
Table: IVD Procedural Volume [excluding blood glucose tests], 2021-2026 (millions)
| Item/Year | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | CAGR |
| POC Self Testing | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| POC Professional Tests | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Clinical Chemistry | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Immunoassays | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Mass Spectrometry (Immuno) | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Molecular | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Hematology | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Coagulation | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Conventional Microbiology | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Mass Spectrometry (Micro) | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Blood Grouping/Typing | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Histology/Cytology | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
| Total | XX Million | XX Million | XX Million | XX Million | XX Million | XX Million | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter One: Executive Summary
- Figure 1-1: Global IVD Procedure Volumes, 2021 and 2026, (in millions $)
IVD Procedure Volume Estimate and Forecast
Scope & Methodology
About Kalorama Information
Chapter Two: Introduction
Industry Trends
- Table 2-1 Global IVD Procedural Volume & Product Sales (includes glucose tests), 2021-2026
COVID 19
Chapter Three: Healthcare Trends
Overview
Demographic Trends
Global Population and Aging
- Table 3-1: Elderly Support Ratio in Various Countries (Australia; Brazil; Canada; China; China, Hong Kong SAR; France; Germany; India; Italy; Japan; Mexico; Saudi Arabia; Singapore; South Africa; Spain; Turkey; United Kingdom; United States; World)
Workforce Reduction
- Table 3-2: Age Under 15 and Over 65, by Continent (Africa, L. America/Caribbean, Asia, Oceania, N. America, Europe, World) 2020
Addressing the Aging Trend
Emerging and Emerged Markets
- Table 3-3: Market Potential by Total Population, and Percent Urban 2021 (China, India, United States, Brazil, Russia, Mexico, Nigeria, Turkey, S. Korea, S. Africa, Vietnam, Poland, Saudi Arabia, Canada, Colombia, Ukraine, Egypt, Malaysia)
Chapter Four: IVD Testing Segments
IVD Testing Trends
- Table 4-1: IVD Procedural Volume including blood glucose tests (millions), 2021-2026
- Table 4-2: IVD Procedural Volume excluding blood glucose tests (millions), 2021-2026
Segment Growth Projections
POC Testing
Clinical Chemistry
Immunoassays
Mass Spectrometry (Immuno)
Molecular Assays
Hematology
Coagulation
Conventional Microbiology
Blood Grouping/Typing
Histology/Cytology
- Table 4-3: IVD Product Sales including blood glucose tests ($ millions), 2021-2026
- Table 4-4 IVD Product Sales excluding blood glucose tests ($ millions), 2021-2026
Chapter Five: Global IVD Markets
General
- Table 5-1: IVD Procedural Volume excluding blood glucose tests by Region (millions), 2021-2026
- Table 5-2: IVD Product Sales excluding blood glucose tests by Region ($ millions), 2021-2026
North America
United States
Canada
Mexico, Central & South America
Brazil
Mexico
Other Central & South America
Argentina
Colombia
Chile
Peru
Venezuela
All Other Countries & Territories
Western Europe
France
Germany
Italy
Spain
United Kingdom
Other Western Europe
Netherlands
Belgium
Austria
Sweden
Switzerland
Denmark
Portugal
Norway
Greece
Ireland
Finland
All Other Countries & Territories
Eastern Europe
Russia
Other Eastern Europe
Poland
Romania
Czech Republic
Ukraine
Hungary
All Other Countries
Asia/Pacific
China
Japan
Other Asian Countries and Territories
India
South Korea
Australia
Taiwan
Vietnam
Pakistan
Thailand
Malaysia
Indonesia
Hong Kong
Philippines
Singapore
New Zealand
All Other Countries & Territories
Middle East
Turkey
Other Middle East
Iran
Saudi Arabia
Iraq
Israel
United Arab Emirates
All Other Countries
Africa
Egypt
South Africa
Nigeria
All Other Countries & Territories
Chapter Six: Point-of-Care (POC) Procedures
Global POC Procedure Volume by Test Type
- Table 6-1: Total POC Procedural Volume & Product Sales including blood glucose tests, 2021-2026
- Table 6-2: Total POC Procedural Volume & Product Sales excluding blood glucose tests, 2021-2026
- Figure 6-1: US/ROW POC Procedure Volumes excluding blood glucose tests by Percent 2026
- Figure 6-2: US/ROW POC Sales excluding blood glucose sales by Percent 2026
POC Self Tests
- Table 6-3: POC Self-Test Procedural Volume by Type (millions), 2021-2026
Traditional Blood Glucose Monitoring Activities
Continuous Blood Glucose Monitoring
Pregnancy and Fertility Testing
Coagulation Testing
Fecal Occult Blood Testing
Drugs of Abuse Testing
Pylori Testing
HIV Testing
Infectious Disease
Cholesterol Testing
POC Urinalysis Testing
Other POC Self-Testing
POC Self-Testing Product Sales
- Table 6-4: POC Self-Test Product Sales by Type ($ millions), 2021-2026
Pricing Trends
- Table 6-5: POC Self-Test $ IVD Product Sales Per Procedure, 2021-2026
POC Professional Testing
- Table 6-6: POC Professional Procedural Volume by Type (millions), 2021-2026
POC Professional Blood Glucose Testing Procedures
POC Professional Critical Care Testing
POC Fertility Testing
POC Professional Infectious Disease Testing
POC Professional Cardiac Marker Testing
POC Professional Cholesterol/Lipid Testing
POC Professional Coagulation Testing
POC Professional HbA1C Testing
POC Professional Hematology Testing
POC Professional Fecal Occult Blood Screening
POC Professional Drugs of Abuse Testing
POC Professional Urinalysis Testing
Other POC Professional Testing
POC IVD Product Sales
- Table 6-7: POC Professional IVD Product Sales by Type ($ millions), 2021-2026
Pricing Trends
- Table 6-8: POC Professional $ IVD Products Per Procedure by Type (millions), 2021-2026
Chapter Seven: Clinical Chemistry Procedures
- Table 7-1: Clinical Chemistry Procedural Volume by Type (millions), 2021-2026
- Figure 7-1: US/ROW Clinical Chemistry Procedure Volumes by Percent 2026
Types of Tests
General Chemistry
Enzymes
Glucose
Lipids
Proteins
Other Compounds
Blood Gases & Electrolytes
Urinalysis
Global Sales of Clinical Chemistry Products
- Table 7-2: Clinical Chemistry Product Sales by Type ($ millions), 2021-2026
- Figure 7-2: US/ROW Clinical Chemistry Sales by Percent 2026
Pricing Trends
- Table 7-3: Clinical Chemistry $ IVD Product Sales Per Procedure ($), 2021-2026
Chapter Eight: Immunoassay Procedures
Technologies
Labeling Techniques
Enzyme Immunoassays
Fluorescence Polarization Immunoassays (FPIAs)
Radioimmunoassays (RIAs)
- Table 8-1: Immunoassay Procedural Volume by Type (millions), 2021-2026
- Figure 8-1: US/ROW Immunoassay Procedure Volumes by Percent 2026
Testing Procedures & Product Sales
- Table 8-2: Immunoassay Product Sales by Type (millions), 2021-2026
- Figure 8-2: US/ROW Immunoassay Sales by Percent 2026
Cardiac Markers
Tumor Markers
Autoimmune Conditions
Allergy Conditions
Thyroid Conditions
Proteins
Anemia
Fertility Testing
Therapeutic Drug Monitoring
Vitamin D
Diabetes/HbA1c
Drugs of Abuse
Infectious Diseases
- Table 8-3: Immunoassay Infectious Disease exc Blood Screening Immuno Procedural Volume by Type (millions), 2021-2026
- Table 8-4: Immunoassay Infectious Disease exc Blood Screening Immuno Product Sales by Type ($ millions), 2021-2026
Instruments
Pricing Trends
- Table 8-5: Immunoassay $ Product Sales Per Procedure by Type, 2021-2026
Chapter Nine: Molecular Testing Procedures
- Table 9-1: Molecular Assay Procedural Volume by Type (millions), 2021-2026
- Figure 9-1: US/ROW Molecular Assay Procedure Volumes by Percent 2026
Types of Test
Testing Technologies
Infectious Diseases
- Table 9-2: Molecular Assay Infectious Disease Procedural Volume by Type (millions), 2021-2026
Blood Screening
Cancer
Transplant Matching
Thrombophilia SNPs
Inherited Diseases
Other Molecular Tests
Prenatal
Global Sales of Molecular IVD Products
- Table 9-3: Molecular Assay Product Sales by Type ($ millions), 2021-2026
- Figure 9-2 : US/ROW Molecular Assay Sales by Percent 2026
- Table 9-4: Molecular Assay Infectious Disease Product Sales by Type ($ millions), 2021-2026
Pricing Trends
- Table 9-5: Molecular Assays $ Products per Procedure by Type, 2021-2026
Chapter Ten: Laboratory-Based Hematology Procedures
- Table 10-1: Laboratory-Based Hematology Procedural Volume by Type (millions), 2021-2026
- Figure 10-1: US/ROW Laboratory-Based Hematology Procedure Volumes by Percent 2026
Types of Tests
Global Sales of Hematology Products
- Table 10-2: Laboratory-Based Hematology Product Sales by Type ($ millions), 2021-2006
- Figure 10-2: US/ROW Hematology Sales by Percent 2026
Pricing Trends
- Table 10-3: Hematology $ Product Sales Per Procedure by Type, 2021-2026
Chapter Eleven: Coagulation Testing Procedures
- Table 11-1: Coagulation Procedural Volume (millions), 2021-2026
- Figure11-1: US/ROW Coagulation Procedure Volumes by Percent 2026
Types of Tests
Global Sales of Coagulation Products
- Table 11-2: Coagulation Product Sales ($ millions), 2021-2026
- Figure 11-2: US/ROW Coagulation Sales by Percent 2026
Pricing Trends
- Table 11-3: Coagulation $ Products per Procedure, 2021-2026
Chapter Twelve: Microbiology Procedures
- Table 12-1: Conventional Microbiology Procedural Volume by Type (millions), 2021-2026
- Figure 12-1: US/ROW Microbiology Procedure Volumes by Percent 2026
Types of Tests
ID/AST Automated Panels & Reagents
Manual Panels & Reagents
Blood Culture
Chromogenic Media
Rapid Microbiological Tests
Mass Spectrometry
Global Sales of Conventional IVD Microbiology Products
ID/AST Panels & Reagents
Blood Culture
Chromogenic Media
Rapid Microbiological Tests
Mass Spectrometry
- Table 12-2: Conventional Microbiology Product Sales by Type ($ millions), 2021-2026
- Figure 12-2: US/ROW Microbiology Sales by Percent 2026
Pricing Trends
- Table 12-3: Conventional Microbiology $ Product Sales Per Procedures by Type, 2021-2026
Chapter Thirteen: Blood Grouping/Typing Procedures
- Table 13-1: Blood Grouping/Typing Procedure Volumes ($ millions), 2021-2026
- Figure 13-1: US/ROW Blood Grouping/Typing Procedure Volumes by Percent 2026
Types of Tests
Blood Grouping/Typing Product Sales
- Table 13-2: Blood Grouping/Typing Product Sales ($ millions), 2021-2026
- Figure 13-2: US/ROW Blood Grouping/Typing Sales by Percent 2026
Pricing Trends
- Table 13-3: Blood Grouping/Matching $ Product Sales/Procedure, 2021-2026
Chapter Fourteen: Histology/Cytology Procedures
- Table 14-1: Histology/Cytology Procedural Volume by Type (millions), 2021-2026
- Figure 14-1: US/ROW Histology/Cytology Procedure Volumes by Percent 2026
Types of Tests
Pap Tests
In Situ Hybridization Tests
Immunohistochemistry Tests
Traditional Non-Pap Stains
Circulating Tumor Cells
Flow Cytometry
Histology/Cytology IVD Product Sales
- Table 14-2: Histology/Cytology Product Sales by Type ($ millions), 2021-2026
- Figure 14-2: US/ROW Histology/Cytology Sales by Percent 2026
Pricing Trends
- Table 14-3: Histology/Cytology $ Product Sales Per Procedure by Type, 2021-2026
Chapter Fifteen: Company Profiles
- Table 15-1: Revenues of Selected Top 19 IVD Companies, 2017-2021 ($ million)
Abbott Diagnostics
Recent Revenue History
- Table 15-2: Abbott Diagnostic Revenues 2017-2021 (millions $)
Alere Acquisition Update and Point of Care
Core Lab
Hematology
Blood Banking
Infectious Diseases – Molecular
Diabetes
HIV Point of Care
i-STAT Business
Agilent Technologies
Recent Revenue History
- Table 15-3: Agilent Revenues 2017-20121 (millions $)
Agilent in Genomics
Cytogenetic Analysis
Sequencing
Flow Cytometry
Companion Diagnostics – Dako
COVID-19
Becton, Dickinson and Company (BD)
Recent Revenue History
- Table 15-4: BD Diagnostic Revenues 2017-2021 (millions $)
Cytology
Molecular Microbiology
Traditional Microbiology – ID/AST
Blood Culture
Hospital Acquired Infections
Blood Collection
Mass Spectrometry
Flow Cytometry
COVID-19
bioMérieux Inc.
Recent Revenue History
- Table 15-5: bioMérieux IVD Revenues 2017-2021 (millions $)
Traditional Microbiology
Blood Culture
Immunoassays
Mass Spectrometry
BioFire Diagnostics Business
COVID-19
Bio-Rad Laboratories, Inc.
Recent Revenue History
- Table 15-6: Bio-Rad Diagnostics Revenues 2017-2021 (millions $)
Blood Bank
Immunoassays
Danaher Corporation
- Table 15-7: Danaher Global IVD Diagnostic Sales, 2017-2021 ($million)
Dexcom
Recent Revenue History
- Table 15-8: Dexcom IVD Diagnostic Sales, 2017-2021 ($million)
DiaSorin
Recent Revenue History
- Table 15-9: DiaSorin Revenues 2017-2021 (millions $)
Immunoassays
Molecular
COVID-19
Exact Sciences
Recent Revenue History
- Table 15-10: Exact Sciences Revenues 2017-2021 (millions $)
COVID-19
Hologic, Inc.
Recent Revenue History
- Table 15-11: Hologic Revenues 2017-2021 (millions $)
PANTHER Molecular System
HIV Testing
Sexually Transmitted Infections
Infectious Diseases
Cytology
COVID-19
Illumina
Recent Revenue History
- Table 15-12: Illumina Diagnostics Revenues 2017-2021 (millions $)
COVID-19
Ortho Clinical Diagnostics (Ortho)
Recent Revenue History
- Table 15-13: Ortho Clinical Diagnostics Revenues 2017-2021 (millions $)
Blood Bank
Core Lab / Immunoassays
COVID-19
PerkinElmer, Inc
Recent Revenue History
- Table 15-14: PerkinElmer IVD Revenues 2017-2021 (millions $)
Diagnostics
COVID-19
QIAGEN
Recent Revenue History
- Table 15-15: QIAGEN IVD Revenues 2017-2021 (millions $)
Tuberculosis
Precision Medicine / Companion Diagnostics
Molecular Microbiology
Prenatal Testing
Next Generation Sequencing
Liquid Biopsy
COVID-19
Roche Diagnostics
Recent Revenue History
- Table 15-16: Roche Diagnostics IVD Revenues 2017-2021 (millions $)
Hematology
Core Lab
Immunoassays
HIV
Core Molecular
Digital PCR
Diabetes Care
Coagulation
cobas Liat System – POC
HPV
Blood Bank
Transplant Medicine
Cancer Companion Testing
COVID-19
Siemens Healthineers (Siemens)
Recent Revenue History
- Table 15-17: Siemens Healthineers IVD Revenues 2017-2021 (millions $)
Core Lab
Immunoassays
Hematology
Molecular
Acute Care – POC
COVID-19
Sysmex Corporation
Recent Revenue History
- Table 15-18: Sysmex IVD Revenues 2017-20121(millions $)
Hematology
Coagulation
Urinalysis
Immunoassays
Flow Cytometry
Precision Medicine / Companion Test Diagnostics
Oncology
COVID-19
Thermo Fisher Scientific Inc.
Recent Revenue History
- Table 15-19: Thermo Fischer IVD Revenues 2017-2021 (millions $)
Immunoassays
Microbiology
Next Generation Sequencing
qPCR
Mass Spectrometry
COVID-19
Werfen
Recent Revenue History
- Table 15-20: Werfen IVD Revenues 2017-2021 (millions $)
Hematology
Advanced Cell Diagnostics (ACD)
Autoimmunity
Related products
Clinical Laboratory Services Market, 8th Edition
May 18, 2023
Laboratories are the workhorse of diagnostic services for the IVD market. These laboratories play a vital role in providing analysis of a wide range of disorders and diseases including pathology, immunology, cholesterol testing, allergy testing, urinalysis, genetic testing and many more. Kalorama Information’s Clinical Laboratory Services Market, 8th Edition is your comprehensive resource for insights…
Price range: $4,000.00 through $6,000.00
Cell and Gene Therapy Deals Analysis, 2021-2024
June 3, 2024
Kalorama Information’s Cell and Gene Therapy Deals Analysis: Financings, Partnering, M&A, Tech Transfers, IPOs/SPACs, Other Deals, 2021-2024 offers a comprehensive look at the dynamic and rapidly evolving cell and gene therapy market. This report highlights the significant deal-making activities that have taken place from Q1 2021 to Q1 2024, providing valuable insights for companies and…
Price range: $6,300.00 through $9,450.00
The World Market for Veterinary Diagnostics, 7th Edition
January 22, 2024
Unlock the potential of the veterinary diagnostics market with Kalorama Information’s comprehensive report, The World Market for Veterinary Diagnostics, 7th Edition, which dives deep into the world of animal healthcare diagnostics. From disease identification to monitoring, veterinarians rely on a variety of tests for accurate diagnoses and effective treatment plans. Our report provides a detailed…
Price range: $5,000.00 through $7,875.00
![30-Country In Vitro Diagnostic (IVD) Market Atlas [October 2023 Update]](https://www.scienceandmedicinegroup.com/wp-content/uploads/2025/06/Kalorama-1.svg)